STEVEN A SHALLCROSS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVEN A SHALLCROSS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN A SHALLCROSS. STEVEN A SHALLCROSS is CEO and CFO in Synthetic Biologics, Inc. ($SYN) and Chief Financial Officer in Synthetic Biologics, Inc. ($SYN) and Interim CEO and CFO in Synthetic Biologics, Inc. ($SYN) and Senior Vice President and CFO in MiddleBrook Pharmaceuticals, Inc. ($AVNC) and Director in Newgioco Group, Inc. ($PNDR).
Latest Insider Trading Transactions of STEVEN A SHALLCROSS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, PNDR, AVNC, SYN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2021 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Buy | P | 0.49 | 50,000 | 24,595 | 100,000 | 50 K to 100 K (+100.00 %) |
Jan 27 2021 | PNDR | Elys Game Technolo ... | SHALLCROSS STEVEN A | Director | Grant | A | 5.72 | 5,245 | 30,001 | 5,245 | 0 to 5.2 K |
Dec 31 2020 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Option Exercise | A | 0.42 | 450,000 | 187,650 | 450,000 | |
Dec 05 2019 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Option Exercise | A | 0.42 | 450,000 | 188,100 | 450,000 | |
Aug 26 2019 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Buy | P | 0.42 | 50,000 | 20,785 | 50,000 | 0 to 50 K |
Jul 08 2019 | PNDR | Newgioco Group, In ... | SHALLCROSS STEVEN A | Director | Option Exercise | A | 0.37 | 2,500 | 925 | 82,500 | |
Dec 07 2018 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | CEO and CFO | Option Exercise | A | 0.69 | 200,000 | 137,900 | 200,000 | |
Dec 21 2017 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | Interim CEO and CFO | Option Exercise | A | 0.52 | 550,000 | 286,000 | 550,000 | |
Dec 02 2016 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | Chief Financial Off ... | Option Exercise | A | 0.80 | 500,000 | 400,000 | 500,000 | |
Dec 04 2015 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | Chief Financial Off ... | Option Exercise | A | 2.76 | 100,000 | 276,000 | 100,000 | |
Jun 01 2015 | SYN | Synthetic Biologic ... | SHALLCROSS STEVEN A | Chief Financial Off ... | Option Exercise | A | 2.16 | 900,000 | 1,944,000 | 900,000 | |
Feb 27 2004 | AVNC | MiddleBrook Pharma ... | SHALLCROSS STEVEN A | Senior Vice Preside ... | Option Exercise | A | 8.45 | 80,000 | 676,000 | 80,000 |
Page: 1